GlassScriptPhysician profile
Edgar H Zambrano
NPI 1780718767
$1,628.85
in general payments reported to CMS, 2019-2025
15 companies · $88.23 in 2025
The $88.23 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $508 · 2020: $545 · 2022: $16.60 · 2023: $123 · 2024: $349 · 2025: $88.23.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $394 · Travel and Lodging: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $393.66 |
| Travel and Lodging | $165.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Merz North America, INC. | $605.98 | 2019-2020 | |
| Intuitive Surgical, INC. | $578.28 | 2019-2024 | |
| Abbvie INC. | $89.73 | 2023 | Botox |
| Solventum Corporation | $58.26 | 2024 | Activ.A.C. |
| Reapplix INC. | $55.61 | 2024 | 3c Patch Kit - Box |
| Cashflow Solutions, LLC | $47.69 | 2024-2025 | Pcd-51 731a (US) - White, Lympha Press Optimal Plus(US) Bt, Pcd-52 737a (US) White |
| Smith+Nephew, INC. | $38.16 | 2024-2025 | Grafix Pl, Oasis, Renasys Touch |
| Mimedx Group, INC. | $37.74 | 2024-2025 | |
| Allergan, INC. | $20.00 | 2019 | |
| Tela Bio, INC. | $19.26 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Kerecis Limited | $18.98 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Galderma Laboratories, L.P. | $16.60 | 2022 | |
| Convatec INC. | $14.48 | 2025 | |
| Integra Lifesciences Corporation | $14.33 | 2019 | |
| Medline Industries LP | $13.75 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Edgar Zambrano listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.